Sarah Anwar

A DNA-based Zika virus vaccine developed by Inovio Pharmaceuticals proves successful in phase I open-label dose-ranging human trials.

Researchers discover that being exposed to latter stages of malaria infection prevents cells from developing immunity to early liver stage infection.

More on the latest news regarding Zika virus research in pregnant women and their growing fetuses is included in this article.

Researchers found that 6% of fetuses or infants congenitally infected with the Zika virus developed birth defects.

The latest news regarding the spread of the Zika virus in the United States, and recent discoveries on how Zika infects the human brain is included in this article.

Researchers from Brazil have developed a platform that can successfully diagnose hundreds of different viruses.

Researchers in a new study have utilized the human antibody response to a salivary peptide in Aedes aegypti mosquitoes to determine the effectiveness of vector-control methods.

Australian students manufactured the $750 pill in their school lab.

Researchers from the University of California-San Francisco tested the ability of 2,177 FDA-approved compounds to reduce viral proliferation in Zika-susceptible cells.

Glaucoma, a serious eye disease that can potentially cause permanent vision loss, was diagnosed in an infant with Zika.

An outbreak of Legionnaires’ disease in Saratoga Springs, New York leaves several ill and two dead.

A Texas resident with no history of travel has been diagnosed with the Zika virus. Officials believe this may be the first case of locally-transmitted Zika in the state.

On their quest to put an end to a threat that may change modern medicine as we know it, researchers discovered four chemicals that disrupt AcrA, an efflux pump protein, that contributes to antibiotic resistance in bacteria.

Lake County General Health District confirmed that a contaminated cooling tower in Ohio was the cause of a 4-month-long outbreak of Legionnaires’ disease, which resulted in one death.

What started as four infections at the University of Missouri has now grown into an outbreak.

The Florida Keys are primed for the release of genetically modified (GM) male Aedes aegypti mosquitoes that pass a self-limiting gene to their offspring.

Although infection with the Zika virus remains a "public health challenge," as it is still circulating in many parts of the world, the World Health Organization no longer deems it one of international concern.

There is a stigma that incoming refugees pose a health risk to European communities. In order to assess the risk of possible outbreaks and jump-start prevention, the European Centre for Disease Prevention and Control (ECDC) recommends implementing a multi-step Syndromic Surveillance system.

A recent report from the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report states that congenital Zika infection may be associated with hearing loss.

On Friday, August 26, 2016, the FDA amended its blood collection guidance, stating that all blood donations in US states and territories be tested for Zika virus infection, to ensure the safety of the nation’s blood supply.

Reports of active transmission in a second area of Florida have been confirmed.

In the first research of its kind, an interdisciplinary group of scientists analyzed three Zika strains in second trimester fetal neural stem cells (fNSC) to identify which viral proteins cause congenital microcephaly. Since Zika causes significant neurological impairment, early diagnosis is imperative.

The El Paso resident is said to have contracted the infection while visiting Miami, Florida, where active Zika transmission has been confirmed

The US Department of Health and Human Services has declared a public health emergency in Puerto Rico, in response to tens of thousands of Zika diagnoses.

As the number of locally-acquired Zika cases rises in Florida, mathematicians are researching a new approach to control vector populations.

According to an update on the environmental review, the FDA considered thousands of comments from the public prior to publishing its final environmental assessment.

WRAIR announced that their Zika purified inactivated virus vaccine succesfully prevented infection in nonhuman primates.

According to IDSA, early diagnosis reduces the need for otherwise unnecessary testing and treatment.

The approach used in the development of this vaccine was previously implemented by NIAID in a West Nile virus vaccine, which was found to be safe and effective in Phase I trials.

The rapid spread of Zika throughout Puerto Rico coupled with the introduction of active transmission in Florida has prompted the Centers for Disease Control and Prevention (CDC) to award millions in Zika funding to US states and territories.